MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--BrightWater Medical, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared the company’s innovative ConvertX™ Nephroureteral Stent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results